Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, reverse transcriptase activity
- 1 February 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (4) , 642-646
- https://doi.org/10.1016/0006-2952(91)90641-h
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- New acquisitions in the development of anti-HIV agentsAntiviral Research, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- RESUMPTION OF HIV ANTIGEN PRODUCTION DURING CONTINUOUS ZIDOVUDINE TREATMENTThe Lancet, 1988
- CASTANOSPERMINE AND OTHER PLANT ALKALOID INHIBITORS OF GLUCOSIDASE ACTIVITY BLOCK THE GROWTH OF HIVThe Lancet, 1987
- New selective antiviral agents active against the AIDS virusTrends in Pharmacological Sciences, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983